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Infantile spasms is diagnosed late even by expert pediatricians. Late diagnosis 
(later than 3 weeks) can have a negative effect on the long-term prognosis. We 
aimed to investigate infantile spasms treated with intravenous methylprednisolone 
pulse. 
Materials & Methods
In this case series study, 20 infants with infantile spasms in 17-Shahrivar Hospital, 
Rasht, Iran were enrolled. Drugs were administered based on Mytinger protocol 
that included 3 days of methylprednisolone pulse and 56 days of oral prednisolone. 
The control of spasms and the omission of hypsarrhythmia in infants follow-
up were the primary and secondary outcomes, respectively. Remission was 
indicated if the caregivers mentioned no spasms or >50% decrease regarding 
drug initiation for at least 5 consecutive days and the electroencephalography 
during sleep period noted the omission of hypsarrhythmia.
Results
Eleven female (55%) and 9 male (45%) patients with the mean age of 4.95±1.39 
months were enrolled. Mean rapid remission was noted as 4.41±1.50 days. 
Twelve patients (60%) noted early remission. seizure was controlled in 3(15%) 
patients completely after 24 months. Five (25%) occasional seizures were noted 
controlled by routine anticonvulsant drugs after 24 months and 12 (60%) no 
response was mentioned. Most of the patients (65%) had cryptogenic etiology 
for infantile spasms. Uncontrolled seizure was mentioned after initial remission.
Conclusion
Methyl prednisolone is an appropriate drug based on easy administering, low 
cost, and its accessibility. 
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Introduction 
Infantile spasms (IS) is an age-dependent myoclonic seizure that occurs in 25 per 
100000 live births. Its etiology can’t be defined in 75% of patients with infantile 
spasms. It usually initiates in 4-8 months after birth (the peak: 4-7 months) and 
always before 1 year of age (1).
According to the international league against epilepsy, infantile spasms are classified 
into symptomatic and cryptogenic types. Commonly, there is a sign of previous brain 
injury or a related to a specific etiology in symptomatic type. However, in cryptogenic 
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Consent letters were obtained from parents and the study 
was approved by Ethics Committee of the hospital.
Spasms were classified into cryptogenic and symptomatic 
types based on history, physical exam, brain MRI, 
and metabolic study. Patients were hospitalized in 
Neurology Ward to treat with methylprednisolone pulse. 
Vital signs were checked and parents were educated. 
In addition, fasting blood sugar, blood pressure and 
urine analysis and culture were monitored. Drugs were 
administered based on Mytinger protocol that included 
3 days of methylprednisolone pulse and 56 days of oral 
prednisolone (Table 1) (10). 
Primary outcome was the control of spasms and the 
second outcome was the omission of hypsarrhythmia 
in infants follow-up. Although prolonged video EEG 
is the most appropriate method for defining response 
but if there is no access, clinicians can consider routine 
EEG as well. Response was indicated if the caregivers 
mentioned no spasms or >50 % decrease regarding drug 
initiation for at least 5 consecutive days and the EEG 
during sleep period noted the omission of hypesarythmia 
(6). The minimum period of response was 2 wk (6, 10). 
The mentioned protocol will be used as a first treatment 
or will be added to the previous ineffective drugs with no 
change in the previous dosage of drugs (11).
Patients were followed up for 24 months after treatment. 
Data were gathered by a form including age, sex, 
etiology, previous treatment, period of spasms control, 
follow-up, EEG, and complications. Data were reported 
by number, percent, mean and standard deviation by 
SPSS software version 19.0 (Chicago, IL, USA). 
Results
Eleven female (55%) and 9 male (45%) patients with 
the mean age of 4.95±1.39 months participated in this 
study. Mean rapid remission was noted as 4.41±1.50 
days. Tweleve patients (60%) noted that early remission. 
Seizure was controlled in 3 (15%) patients completely 
after 24 months. Five (25%) occasional seizures were 
noted controlled by routine anticonvulsant drugs after 
24 months and 12 (60%) no response was mentioned. 
At the follow-up EEG, 13 patients (65%) were normal 
and 7 (35%) abnormal cases were noted. Most of the 
patients (65%) had cryptogenic etiology for infantile 
spasms. Seven (35%) repeated seizures, 5 (25%) 
type, no sign of brain injury or specific etiology can be 
noted. As infantile spasms is a medical emergency, early 
diagnosis especially for cryptogenic type is mandatory (2).
Generally, infantile spasms diagnoses late even by 
expert pediatricians and late diagnosis (later than 3 wk) 
can have a negative effect on the long-term prognosis 
(3). It is generally distinguished with common infantile 
disorders such as infantile colic. Electroencephalography 
is the most important method of diagnosis of infantile 
spasms showed by hypsarrhythmia. (1)
Although the ultimate development of infants depends 
on the cause but most of them encounter with diverse 
types of seizures and psychomotor retardation (4).
There is no specific treatment preferred in contrast with 
other types of treatment (5). American Academy of 
Neurology and pediatrics neurology society mentioned 
that there is no document that successful treatment can 
affect late prognosis. ACTH can be noted as a short-
term treatment for infantile spasms, and vigabatrin can 
be effective (2). Although, ACTH is the traditional 
treatment of IS, however, oral prednisolone with the 
dosage of 2-4 mg/ kg/d for 8 wk can be an alternative 
method (1). Generally, 25%-33% of recurrence occurs 
after any type of treatment (6). Although, the preference 
of ACTH was reported on prednisolone but that can be 
effective when no response is reported by administering 
ACTH and vice versa (7).
Worldwide, ACTH is an expensive drug with a low access 
(scarce access), therefore, according to safety, cheap and 
easily accessible of intravenous methylprednisolone (8, 
9), we aimed to investigate the effect of intravenous 
methylprednisolone pulse on the infantile spasms in 
patients hospitalized in 17-Shahrivar Hospital, Rasht, 
Iran 
Materials & Methods
This observational case series study was conducted on 
20 infants with IS hospitalized in 17 Shahrivar Hospital, 
Rasht, Iran during 2011-2014. Infants aged less than 1 
year and more than 1 month with any etiology of spasms 
except tuberous sclerosis (vigabatrin is their choice 
treatment) (3), symptom of spasms and Hypsarrhythmia 
in EEG were included. Patients with kidney disease, 
hypertension, cardiac disease, and febrile or infectious 
diseases were excluded. 
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occasional seizures, 2 (10%) refractory seizures and 3 
(15%) uncontrolled seizure were mentioned after initial 
remission. Besides, no seizure was noted in 3 (15%) 
patients after initial remission. Seven patients (35%) 
received only methylprednisone and methylprednisolone 
was added to previous drugs in 13 patients. No 
complication was noted in most of the patients (13 
cases). However, 5-weight gain, one asymptomatic 
glucosuria, and 1 irritability were noted in patients with 
infantile spasms (Table 2).
Discussion
According to results, 60% of patients noted remission 
which was consistent with Mytinger et al. They also 
indicated 50% remission after administering pulse 
methyl predinsolone.(10) Azam et al compared 
remission by administering ACTH (33 patients )and 
oral predinsolone(72 patients)  in 105 infants with 
infantile spasms. They mentioned improvement in 27 
patients who received ACTH. From these 27 patients, 
11 remained spasm free. 51 patients in oral predinsolone 
group responded and 17 remained spasm free after 
cessation the drug.   Also, administering high dose oral 
predinsolone in patients with infantile spasms indicated 
67% spasm free during 2 weeks. (11)LUX et al reported 
54%, 76%, and 73% improvement by administering 
vigabatrin, ACTH and oral  predisolone in 208 patients 
with infantile spasms. (12)
In this study mean rapid remission was mentioned 
as 4.41±1.50 days which was similar with previous 
investigation. They noted rapid remission in 2-6 days. 
(10).
At the follow up, 13 patients(65%) were normal and 7 
(35%)abnormal cases were noted. However, mytinger et 
al noted lower rate of normal results(50%)(10)
Although our results indicated no complication in most of 
the patients by administering pulse methylpredinsolone. 
But mytinger et al indicated asymptomatic hypertension 
and probable adrenal insufficiency in patients treated 
with pulse methyl predinsolone. LUX et al noted 19 
complications including gasterointestinal complication, 
irritability, drowsiness, infection, increased appetite, 
dermatological complication, mood disturbance, and 
neuropsychiatric disorders by administering oral 
predinsolone. However, they noted lower complications 
by administering ACTH and vigabatrin. (12) Kossoff 
et al noted 53% complications in patients received oral 
predinsolone including irritability, edema, weight gain 
and hypertension. (13) 
  As clinicians hospitalize patients for a short period of 
time (3 days) to administer pulse methyl predinsole and 
during hospitalization, short term Complications of the 
pulse can be detected directly by clinicians and parents 
can be completely educated for follow up; Investigators 
proffered it versus oral type. Also, patients hospitalized 
can be better evaluated before treatment especially for 
asymptomatic infections and emergently clinicians can 
manage probable complications, it seems that Pulse 
methyl predinsolone can be recommended as a choice 
of treatment.  Regarding similar effects of pulse methyl 
predinsolone in comparison with ACTH, it seems that 
methyl predinsolone is a preferable drug regarding easy 
administering, low cost and its  accessibility.
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Table 1. Protocol for intravenous methylprednisolone with oral prednisolone
Medication Time period Dose (mg/kg)
Intravenous methylprednisolone Day 1-3 20/day
Oral prednisolone
Day 4-17 (2 wk)
Day 18-31 (2 wk)
Day 32-45 (2 wk) 
Day 46-52 (1 week) 
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Follow up EEG treatment Late remission complication
1 3 F Cryptogenic 5 3 
Abnormal 
(hypsarrythmia)
MP1 No seizure Weight gain 




3 5 F PKU 21 2 Abnormal MP+TPM+PB Occasional seizure -




5 4 F Structural 12 4 Normal MP Occasional seizure -
6 3 F Cryptogenic 8 6 Normal MP+PB+CLB4 No seizure Weight gain 




12 No response Normal MP+CZP5 +PB Repeated seizure -
9 3 F Cryptogenic 8 5 Normal MP+PB+NZP6 No seizure Weight gain 
10 5.5 M Cryptogenic 17 3 Normal MP+PB+NZP Occasional seizure -
11 5 M Cryptogenic 14 5 Abnormal MP+PB+TPM7 Occasional seizure Weight gain 
12 6.5 M Structural 20 No response Normal MP Refractory seizure -
13 3.5 F CMV 10 4 Normal MP+PB+TPM+LTG8 Occasional seizure -
14 5 M Cryptogenic 10 3 Abnormal MP+PB+CZP Repeated seizure -
15 8 F Cryptogenic 60 No response Normal MP Refractory seizure 
Asymptomatic 
glucosuria 
16 5 M Cryptogenic 12 6 Normal MP+PB+TPM Repeated seizure -
17 4.5 F Down syndrome 17 5 Abnormal MP+PB+NZP Repeated seizure -
18 7 M Cryptogenic 21 No response Normal MP Repeated seizure Weight gain 
19 5 M structural 15 7 Normal MP Repeated seizure -
20 5 F Cryptogenic 10 No response Normal MP+CZP+LTG Repeated seizure -
 
1MP:Methylprednisolone, 2PB: Phenobarbital, 3CZP: Certolizumab pegol, 4CLB: Clobazam, 5CZP: Clonazepam, 6NZP:Nitrazepam, 7TPM:Topiramate, 8LTG:Lamotrigine
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